Cas no 76319-28-3 (rac-ethyl (1R,2R,5S)-3-azabicyclo3.1.0hexane-2-carboxylate)
rac-ethyl (1R,2R,5S)-3-azabicyclo3.1.0hexane-2-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- 3-Azabicyclo[3.1.0]hexane-2-carboxylicacid, ethyl ester, [1R-(1a,2a,5a)]- (9CI)
- 3-Azabicyclo[3.1.0]hexane-2-carboxylicacid,ethylester,[1R-(1-alpha-,2-alpha-,5-alpha-)]-(9CI)
- 3-Azabicyclo[3.1.0]hexane-2-carboxylicacid,ethylester,[1R-(1-α-,2-α-,5-α-)]-(9CI)
- rac-ethyl (1R,2R,5S)-3-azabicyclo3.1.0hexane-2-carboxylate
- EN300-27731784
- rac-ethyl (1R,2R,5S)-3-azabicyclo[3.1.0]hexane-2-carboxylate
- 72496-48-1
- 3-Azabicyclo[3.1.0]hexane-2-carboxylicacid,ethylester,(1-alpha-,2-alpha-,5-alpha-)-(9ci)
- 76319-28-3
-
- Inchi: 1S/C8H13NO2/c1-2-11-8(10)7-6-3-5(6)4-9-7/h5-7,9H,2-4H2,1H3/t5-,6-,7-/m1/s1
- InChI Key: QJFZMDWMBRUEMA-FSDSQADBSA-N
- SMILES: O(CC)C([C@H]1[C@@H]2C[C@@H]2CN1)=O
Computed Properties
- Exact Mass: 155.09500
- Monoisotopic Mass: 155.094628657g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 11
- Rotatable Bond Count: 3
- Complexity: 181
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 3
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.5
- Topological Polar Surface Area: 38.3?2
Experimental Properties
- PSA: 38.33000
- LogP: 0.48620
rac-ethyl (1R,2R,5S)-3-azabicyclo3.1.0hexane-2-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Enamine | EN300-27731784-1g |
rac-ethyl (1R,2R,5S)-3-azabicyclo[3.1.0]hexane-2-carboxylate |
76319-28-3 | 1g |
$0.0 | 2023-09-10 | ||
| Enamine | EN300-27731784-1.0g |
rac-ethyl (1R,2R,5S)-3-azabicyclo[3.1.0]hexane-2-carboxylate |
76319-28-3 | 95.0% | 1.0g |
$0.0 | 2025-03-19 |
rac-ethyl (1R,2R,5S)-3-azabicyclo3.1.0hexane-2-carboxylate Related Literature
-
Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
-
Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
-
Hui Liu,Deyong Su,Guolin Cheng,Jimin Xu,Xinyan Wang,Yuefei Hu Org. Biomol. Chem., 2010,8, 1899-1904
-
Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
Additional information on rac-ethyl (1R,2R,5S)-3-azabicyclo3.1.0hexane-2-carboxylate
Rac-Ethyl (1R,2R,5S)-3-Azabicyclo[3.1.0]Hexane-2-Carboxylate: A Comprehensive Overview
The compound rac-ethyl (1R,2R,5S)-3-azabicyclo[3.1.0]hexane-2-carboxylate (CAS No. 76319-28-3) is a unique bicyclic compound with significant potential in various chemical and pharmaceutical applications. This compound belongs to the class of bicyclic amines and is characterized by its rigid bicyclic structure, which plays a crucial role in its biological activity and chemical reactivity.
The bicyclic structure of this compound is a key feature that contributes to its stability and selectivity in various reactions. The azabicyclo[3.1.0]hexane framework is a six-membered ring system with one nitrogen atom, creating a rigid and strained environment that enhances its reactivity in certain chemical transformations. Recent studies have shown that such bicyclic systems are highly valuable in the design of novel bioactive molecules due to their ability to mimic natural product frameworks.
One of the most notable aspects of rac-ethyl (1R,2R,5S)-3-azabicyclo[3.1.0]hexane-2-carboxylate is its stereochemistry. The compound exists as a racemic mixture, meaning it contains equal amounts of the two enantiomers: (1R,2R,5S) and (1S,2S,5R). This stereochemical property is critical in pharmaceutical applications, where the stereochemistry of a molecule can significantly influence its pharmacokinetics and efficacy.
Recent advancements in synthetic chemistry have enabled the efficient synthesis of this compound through various methodologies. For instance, researchers have employed ring-closing metathesis and stereoselective alkylation techniques to construct the azabicyclo framework with high precision. These methods not only enhance the yield but also allow for better control over the stereochemistry of the final product.
In terms of applications, rac-ethyl (1R,2R,5S)-3-azabicyclo[3.1.0]hexane-2-carboxylate has shown promise in drug discovery programs targeting various therapeutic areas. Its rigid structure makes it an ideal candidate for designing molecules with high binding affinity to specific biological targets such as enzymes and receptors.
Moreover, this compound has been extensively studied for its potential as a building block in medicinal chemistry. Its ability to undergo various functional group transformations makes it versatile for constructing complex molecular architectures. For example, researchers have utilized this compound as a starting material for synthesizing bioactive agents with potential anti-inflammatory and anticancer properties.
The carboxylate group present in this compound adds another layer of functionality by enabling further modifications such as esterification or amidation. These modifications can significantly alter the physicochemical properties of the molecule, making it suitable for different biological assays and pharmacological evaluations.
In conclusion, rac-ethyl (1R,2R,5S)-3-azabicyclo[3.1.0]hexane-2-carboxylate is a versatile and intriguing compound with a wide range of applications in organic synthesis and drug discovery. Its unique bicyclic structure, stereochemical properties, and functional versatility make it an invaluable tool for researchers in the field of chemical biology.
76319-28-3 (rac-ethyl (1R,2R,5S)-3-azabicyclo3.1.0hexane-2-carboxylate) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)